Larvicidal activity of the essential oil from Lippia sidoides Cham. against Aedes aegypti Linn.

被引:130
作者
Carvalho, AFU
Melo, VMM
Craveiro, AA
Machado, MIL
Bantim, MB
Rabelo, EF
机构
[1] Univ Fed Ceara, Dept Biol, BR-60455900 Fortaleza, Ceara, Brazil
[2] Univ Fed Ceara, Parque Desenvolvimento Tecnol, BR-60455900 Fortaleza, Ceara, Brazil
来源
MEMORIAS DO INSTITUTO OSWALDO CRUZ | 2003年 / 98卷 / 04期
关键词
Lippia sidoides; larvicidal activity; thymol;
D O I
10.1590/S0074-02762003000400027
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
The aim of this work was to study the larvicidal activity of Lippia sidoides essential oil against Aedes aegypti larvae. The essential oil and its hydrolate (saturated solution of essential oil in water) were obtained by vapor extraction and their chemical composition determined by GL-chromatography coupled to mass spectroscopy. Bioassays were run with the essential oil, pure and diluted hydrolate and with their main constituents thymol and carvacrol. The results obtained showed that L. sidoides essential oil and its hydrolate have larvicidal action against the mosquito A. aegypti, causing an almost instantaneous mortality. Thymol, an alkylated phenol derivative and one of the major components of L. sidoides essential oil, was identified as the active principle responsible for the larvicidal action, causing 100% larval mortality at the lowest tested concentration of 0.017% (14,A). These results suggest that the essential oil of L. sidoides is promising as larvicide against A. aegypti and could be useful in the search of newer, more selective, and biodegradable larvicidal natural compounds to be used in official combat programs and at home.
引用
收藏
页码:569 / 571
页数:3
相关论文
共 11 条
[1]  
[Anonymous], 1994, PRINCIPAIS MOSQUITOS, DOI DOI 10.7476/9788575412909
[2]  
BANTIM MB, 2000, MONOGRAPH U FEDERAL
[3]  
CEPLEANU F, 1993, THESIS U LAUSANNE LA
[4]  
*EPA, THYM RER EL DEC RED
[5]  
GLUBER D, 1989, AM J TROP MED HYG, V40, P571
[6]  
*GOOD SCENTS CO, MAT SAF DAT SHEET TH
[7]  
LITCHFIELD JT, 1949, J PHARMACOL EXP THER, V96, P99
[8]  
MAILLARD M, 1993, HUMAN MED AGENT PLAN
[9]  
Matos F.J.A, 1994, FARMACIAS VIVAS
[10]  
*MERCK CO, 1976, ENC CHEM DRUGS, P238